Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (61-70 of 365) with videos related to

Pageof 37
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging InitiativeKathryn A Ellis, Christopher C Rowe, Victor L Villemagne, et al.
Neuroimage. Clinical|January 5, 2021
In vivo microstructural heterogeneity of white matter lesions in healthy elderly and Alzheimer's disease participants using tissue compositional analysis of diffusion MRI dataRemika Mito, Thijs Dhollander, Ying Xia, et al.
Journal of Alzheimer'S Disease : JAD|January 22, 2024
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer's Disease and Cognitively Normal IndividualsVictor L Villemagne, Vincent Doré, Lee Chong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2017
Management Impact of Imaging Brain Vesicular Monoamine Transporter Type 2 in Clinically Uncertain Parkinsonian Syndrome with <sup>18</sup>F-AV133 and PETPaschal K Alexander, Yenni Lie, Gareth Jones, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2016
Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid ScaleChristopher C Rowe, Gareth Jones, Vincent Doré, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 24, 2026
Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's diseaseJanice Wong, Tina Wang, Ritobrato Datta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Characterization of PiB binding to white matter in Alzheimer disease and other dementiasMichelle T Fodero-Tavoletti, Christopher C Rowe, Catriona A McLean, et al.
Alzheimer'S Research & Therapy|June 5, 2019
Avoiding methodological bias in studies of amyloid imaging results disclosureCarl Taswell, Cheryl Donohue, Maree T Mastwyk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 12, 2013
Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementiaChristopher C Rowe, Svetlana Pejoska, Rachel S Mulligan, et al.
International Review of Psychiatry (Abingdon, England)|January 16, 2014
The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementiaCassandra E I Szoeke, Joanne S Robertson, Christopher C Rowe, et al.
Pageof 37

Showing results (61-70 of 365) with videos related to

Sort By:
Pageof 37
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging InitiativeKathryn A Ellis, Christopher C Rowe, Victor L Villemagne, et al.
Neuroimage. Clinical|January 5, 2021
In vivo microstructural heterogeneity of white matter lesions in healthy elderly and Alzheimer's disease participants using tissue compositional analysis of diffusion MRI dataRemika Mito, Thijs Dhollander, Ying Xia, et al.
Journal of Alzheimer'S Disease : JAD|January 22, 2024
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer's Disease and Cognitively Normal IndividualsVictor L Villemagne, Vincent Doré, Lee Chong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2017
Management Impact of Imaging Brain Vesicular Monoamine Transporter Type 2 in Clinically Uncertain Parkinsonian Syndrome with <sup>18</sup>F-AV133 and PETPaschal K Alexander, Yenni Lie, Gareth Jones, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2016
Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid ScaleChristopher C Rowe, Gareth Jones, Vincent Doré, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 24, 2026
Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's diseaseJanice Wong, Tina Wang, Ritobrato Datta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Characterization of PiB binding to white matter in Alzheimer disease and other dementiasMichelle T Fodero-Tavoletti, Christopher C Rowe, Catriona A McLean, et al.
Alzheimer'S Research & Therapy|June 5, 2019
Avoiding methodological bias in studies of amyloid imaging results disclosureCarl Taswell, Cheryl Donohue, Maree T Mastwyk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 12, 2013
Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementiaChristopher C Rowe, Svetlana Pejoska, Rachel S Mulligan, et al.
International Review of Psychiatry (Abingdon, England)|January 16, 2014
The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementiaCassandra E I Szoeke, Joanne S Robertson, Christopher C Rowe, et al.
Pageof 37